Deep brain stimulation (DBS) has become the treatment of choice for advanced stages of
Parkinson's disease, medically intractable essential tremor, and complicated segmental and …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the …

Summary Background Patients with advanced Parkinson's disease often have rapid swings
between mobility and immobility, and many respond unsatisfactorily to adjustments in …

OBJECTIVE Thalamotomy of the ventral intermediate nucleus (VIM) is effective in alleviating
medication-resistant tremor in patients with essential tremor (ET) and Parkinson's disease …

Parkinson disease is a complex, multifactorial neurodegenerative disease. Although a
heritable basis was originally thought unlikely, recent studies have implicated several genes …

Parkinson's disease (PD) is a neurodegenerative illness and has a common onset between
the ages of 55 and 65 years. There is progressive development of both motor and non-motor …

Background Deep brain stimulation of the subthalamic nucleus (STN DBS) is an
increasingly common treatment for Parkinson's disease. Qualitative reviews have concluded …

Medications, psychotherapy, and other treatments are effective for many patients with
psychiatric disorders. However, with currently available interventions, a substantial number …

OBJECTIVE: The growing clinical acceptance of neurostimulation technology has
highlighted the need to accurately predict neural activation as a function of stimulation …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms
including tremor and bradykinesia. The primary pathophysiology underlying PD is the …